Published on in Vol 8 , No 11 (2020) :November
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/22997, first published
.

Journals
- Cochran J, Fang H, Le Gallo C, Peters-Strickland T, Lindenmayer J, Reuteman-Fowler J. Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia. Patient Preference and Adherence 2022;Volume 16:1805 View
- Simões de Almeida R, Marques A. User engagement in mobile apps for people with schizophrenia: A scoping review. Frontiers in Digital Health 2023;4 View
- Jakob R, Harperink S, Rudolf A, Fleisch E, Haug S, Mair J, Salamanca-Sanabria A, Kowatsch T. Factors Influencing Adherence to mHealth Apps for Prevention or Management of Noncommunicable Diseases: Systematic Review. Journal of Medical Internet Research 2022;24(5):e35371 View
- Kwon S, Firth J, Joshi D, Torous J. Accessibility and availability of smartphone apps for schizophrenia. Schizophrenia 2022;8(1) View
- Pennou A, Lecomte T, Potvin S, Riopel G, Vézina C, Villeneuve M, Abdel-Baki A, Khazaal Y. A Mobile Health App (ChillTime) Promoting Emotion Regulation in Dual Disorders: Acceptability and Feasibility Pilot Study. JMIR Formative Research 2023;7:e37293 View
Books/Policy Documents
- Baumeister A, Rüegg N, Lüdtke T, Moritz S. Digitale Gesundheitsinterventionen. View